Flavonoids, compounds present in many dietary supplements, affect growth of different bacterial species when tested as purified or synthetic substances. Here, we asked if soy isoflavone extracts, commonly used in many products sold as anti-menopausal dietary supplements, influence bacterial growth similarly to synthetic isoflavone, genistein. Four commercially available products were tested in amounts corresponding to genistein concentrations causing inhibition of growth of Vibrio harveyi (a model bacterium sensitive to this isoflavone) and Escherichia coli (a model bacterium resistant to genistein). Differential effects of various extracts on V. harveyi and E. coli growth, from stimulation, through no changes, to inhibition, were observed. Moreover, contrary to genistein, tested extracts caused a decrease (to different extends) in viability of human dermal fibroblasts. These results indicate that effects of various soy isoflavone extracts on bacterial growth and viability of human cells are different, despite similar declared composition of the commercially available products.
Compositions are as provided by manufacturers; a.n.s., amount not specified by manufacturer
Monitoring of bacterial growth
Bacteria were cultured overnight under conditions described above. Following dilution of the culture with fresh medium, at the v/v ratio 1:100, bacteria were cultured under the same conditions, and A595 was measured every 15 min. The extracts were purchased in the form of tablets, which were crushed and dissolved in DMSO. Such extracts were added to the bacterial cultures at A595 = 0.1 to final concentrations corresponding to 30, 60 and 100 μM genistein (included in each extract). In control experiments, either DMSO (negative control) or genistein (positive control) was added.
Growth curves were analyzed, and bacterial generation times were calculated on the basis of A595
values at the exponential phase of bacterial culture growth. 
MTT cell viability assay

Results and Discussion
It was reported previously that determination of growth rate, particularly generation time, in a liquid culture can be considered as an optimal method for estimation of effects of flavonoids on bacteria [13] . This is because methods based on diffusion are problematic due to low rate of diffusion of flavonoids, and other factors (like inoculum size, disk size, incubation period) may influence the results [22] . Therefore, to determine if tested soy isoflavone extracts influence growth of two bacterial species, V. harveyi (previously demonstrated to be sensitive to genistein [7, 13] ), and E. coli (previously demonstrated to be resistant to genistein [7, 13] ), we monitored growth of bacterial liquid cultures and calculated generation times in the presence and absence of isoflavone(s).
Representative growth curves are presented in Fig. 1 (for V. harveyi) and Fig. 2 (for E. coli), and calculated generation times are shown in Table 2 (for V. harveyi) and Table 3 (for E. coli). Generation These results indicated that despite using the same concentrations of soy isoflavones (among which genistein is highly predominated [23] ) present in various commercially available products, as declared by extract manufacturers, their effects on bacterial growth were different. These differences might arise from either discrepancies between declared (by manufacturers) and actual amounts of isoflavones in tablets (the phenomenon reported previously for other extracts [16] ) or activities of other compounds (either identified molecules or unidentified substances from extracts or both) present in the products (see Table 1 ). Irrespective of the cause of this phenomenon, differential effects of tested extracts on bacterial growth are evident. This might be especially important in the light of recent studies which demonstrated that flavonoids can significantly influence human gut microbiome [8, 10] .
Other differential biological effects of various soy isoflavone extracts were reported previously,
when synthesis of glycosaminoglycans was tested in human fibroblasts [16] . Therefore, we have also Generation times were calculated in two periods: between 0 and 30 min after addition of genistein or extract (or DMSO in control experiments), and between 60 and 120 min after addition of genistein or extract (or DMSO in control experiments).
Results are presented as mean values from at least 3 independent experiments ± SD. p values were calculated using the t-test, statistically significant differences were assumed when
p<0.05 (values marked with asterisks).
N/A, not applicable.
In control experiments, according to previously published results [24] , we found no significant cytotoxic effects of synthetic genistein (Figs. 3 and 4) . However, 24 h incubation with extracts were enough to decrease viability of human fibroblasts by extract 1 (at all tested concentrations) and extracts 2 and 3 at certain concentrations (Fig. 3) . Even more pronounced cytotoxic effects were observed after 48 h incubation, when viability of human cells was significantly decreased, particularly in the presence of extracts 1 and 2, and to some extend in the presence of extracts 3 and 4 (Fig. 4) .
These results indicated again that various soy isoflavone extracts exhibit differential biological activities despite the same declared (by manufacturers) content of isoflavones. This is true for effects on both bacterial and human cells. Although synthetic genistein demonstrated high level of safety both in vitro [24] and in vivo during clinical studies [25] , as well as beneficial profile of antimicrobial effects [13] , confirmed in this study, some extracts revealed significant effects on E. coli growth, and their cytotoxicity to human fibroblasts was also detected. Since it was demonstrated that different flavonoids can shape unique gut microbiota profile [26] , one might assume a potential influence of isoflavone-rich diet supplements or nutraceuticals on human intestinal flora. It is worth reminding that studies from different countries indicated huge variability in compositions of different soy isoflavone extracts. Setchell et al. [14] analyzed 33 phytoestrogen supplements and extracts, derived from different countries (USA, The Netherlands, and UK) and found considerable differences in the isoflavone content from that claimed by the manufacturers; in some products the differences were 5 to 10-fold, and one product contained no detectable amount of isoflavones. The level of impurities was high in most of the products. Chua et al. [15] found that among 13 commercially available extracts (purchased in the Washington State, USA), only 4 contained at least 90% of the isoflavone content claimed on the label. Moreover, in 2 products, impurities exceeded 40% of the total mass of the extract. Piotrowska et al. [16] analyzed 7 commercially available soy isoflavone extracts, and determined that amounts of isoflavones were similar to those declared by manufacturers in only 3 of them. Other products contained significantly less isoflavones than claimed on the label, while one contained 200-fold lower level. Considerable contaminations were detected in isoflavone-poor extracts. These facts should be taken into account when the use of soy isoflavone extracts is considered, especially as local concentrations of the compounds included in a tablet can be high in human intestine after oral administration of these nutraceuticals or dietary supplements. 
